United States - English - NLM (National Library of Medicine)

terrain pharmaceuticals - betamethasone acetate (unii: ti05ao53l7) (betamethasone - unii:9842x06q6m), betamethasone sodium phosphate (unii: 7bk02scl3w) (betamethasone - unii:9842x06q6m) - betamethasone acetate 3 mg in 1 ml - when oral therapy is not feasible, the intramuscular use of betamethasone sodium phosphate and betamethasone acetate injectable suspension is indicated as follows: allergic states control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. dermatologic diseases bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (stevens-johnson syndrome). endocrine disorders congenital adrenal hyperplasia, hypercalcemia associated with cancer, nonsuppurative thyroiditis. hydrocortisone or cortisone is the drug of choice in primary or secondary adrenocortical insufficiency.  synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular

United States - English - NLM (National Library of Medicine)

terrain pharmaceuticals - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987) - lidocaine hydrochloride anhydrous 10 mg in 1 ml - lidocaine hydrochloride injection, usp is indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed. lidocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.

Australia - English - Department of Health (Therapeutic Goods Administration)

melrose wheelchairs pty ltd - 46137 - multi-terrain sports wheelchair, attendant/occupant-driven - melrose wheelchairs are a custom built lightweight manual wheelchair for the purpose of independant mobility by persons with a disbility.

Australia - English - Department of Health (Therapeutic Goods Administration)

ksm mobility beach chairs - 46137 - multi-terrain sports wheelchair, attendant/occupant-driven - mobile chair device to allow persons with disabilities and others to access and float in the water at beaches, rivers, pools with assistance of a support person.

Australia - English - Department of Health (Therapeutic Goods Administration)

avant innovations - 46137 - multi-terrain sports wheelchair, attendant/occupant-driven - wheelchair for accessing beach and hydrotherapy activities

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sumitomo chemical australia pty. limited - flumioxazin - water dispersible granule - flumioxazin cyclohexanediones active 500.0 g/kg - herbicide

United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals inc. - menthol, unspecified form (unii: l7t10eip3a) (menthol - unii:l7t10eip3a), lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987) - lidothol gel is contraindicated in patients with a known history of sensitivity to local anesthetics of the amide type, or to any other component of the product.

United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals, inc. - ketorolac tromethamine (unii: 4eve5946bq) (ketorolac - unii:yzi5105v0l) - carefully consider the potential benefits and risks of ketorolac tromethamine and other treatment options before deciding to use ketorolac. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). acute pain in adult patients ketorolac tromethamine is indicated for the short-term (≤5 days) management of moderately severe acute pain that requires analgesia at the opioid level, usually in a postoperative setting. therapy should always be initiated with intravenous or intramuscular dosing of ketorolac tromethamine, and oral ketorolac tromethamine is to be used only as continuation treatment, if necessary. the total combined duration of use of ketorolac tromethamine injection and oral ketorolac tromethamine is not to exceed 5 days of use because of the potential of increasing the frequency and severity of adverse reactions associated with the recommended doses (see warnings, precautions, dosage and administr

United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals inc. - menthol, unspecified form (unii: l7t10eip3a) (menthol - unii:l7t10eip3a), lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987) - lidothol is a formulation used to assist patients in the treatment of mild to moderate acute or chronic aches or pain. muscle or joint pain can be due to muscle or ligament strains, simple backache, tendonitis, osteoarthritis, rheumatoid arthritis, peripheral neuropathies such as diabetic neuropathy or post herpetic neuralgia, and other complex regional pains. it can also be used to help with certain types of headaches, but use with caution when applying in order to avoid eye contact. other uses may be considered if deemed clinically relevant. lidothol is contraindicated in patients with a known history of sensitivity to local anesthetics of the amide type, or to any other component of the product.

United States - English - NLM (National Library of Medicine)

terrain pharmaceuticals - lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987), menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a) - topical anesthetic topical analgesic for the temporary relief of pain.